Alnylam Pharmaceuticals (ALNY): Q3 EPS of -$0.38 misses by $0.07. Revenue of $16.8M (-20% Y/Y)...

|About: Alnylam Pharmaceuticals,... (ALNY)|By:, SA News Editor
Alnylam Pharmaceuticals (ALNY): Q3 EPS of -$0.38 misses by $0.07. Revenue of $16.8M (-20% Y/Y) in-line. (PR)